1. Home
  2. SXT vs VKTX Comparison

SXT vs VKTX Comparison

Compare SXT & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensient Technologies Corporation

SXT

Sensient Technologies Corporation

HOLD

Current Price

$87.20

Market Cap

3.7B

Sector

Industrials

ML Signal

HOLD

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$29.94

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXT
VKTX
Founded
1882
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
SXT
VKTX
Price
$87.20
$29.94
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$110.00
$88.00
AVG Volume (30 Days)
215.8K
2.2M
Earning Date
04-24-2026
04-22-2026
Dividend Yield
1.89%
N/A
EPS Growth
7.48
N/A
EPS
3.16
N/A
Revenue
$1,396,499,000.00
N/A
Revenue This Year
$9.05
N/A
Revenue Next Year
$8.65
N/A
P/E Ratio
$27.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$67.79
$18.92
52 Week High
$121.54
$43.15

Technical Indicators

Market Signals
Indicator
SXT
VKTX
Relative Strength Index (RSI) 41.41 39.28
Support Level $82.76 $25.67
Resistance Level $98.60 $30.15
Average True Range (ATR) 2.47 1.91
MACD 0.02 -0.43
Stochastic Oscillator 41.89 1.05

Price Performance

Historical Comparison
SXT
VKTX

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: